The scientists found that two medications significantly reduce the risk of developing dementia in life. A new study, published in JAMA Neurology, finds that people with type 2 diabetes who take two ...

Treating kidney disease GLP-1s show higher risk than SGLT2 inhibitors in kidney outcomes, but lower albuminuria and mortality rates.

Jardiance (empagliflozin) is a brand-name drug that’s prescribed for type 2 diabetes and more. As with other drugs, Jardiance can cause side effects, such as vaginal yeast infections and urinary tract ...

Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced positive top-line results from EMPA-REG OUTCOME ®. This is a long-term clinical trial investigating cardiovascular (CV) ...

Jardiance (empagliflozin) is prescribed to help manage type 2 diabetes and lower the risk of complications from heart failure and chronic kidney disease. Jardiance comes as an oral tablet. This drug ...

Ann & Robert H. Lurie Children’s Hospital of Chicago is leading a clinical trial for a potential treatment of the most prevalent liver disease in children, which currently has no effective treatment.

Maryland’s Prescription Drug Affordability Board says it has identified two diabetes drugs that could be made more affordable for residents based on a cost study by the state agency. During a meeting ...